ArticleCancer biomarkers : section A of Disease markers2019

MiR-153 inhibits the resistance of lung cancer to gefitinib via modulating expression of ABCE1.

Lihong Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.